TP53 and lung carcinoma: Comparison of the AFs of TP53 mutations between smokers and non-smokers with lung cancer revealed that the AFs were significantly higher in smokers with lung cancer (smokers: 32.1 ± 3.1 versus non-smokers: 12.5 ± 5.6, p = 0.003).